A University of Utah physicist took a step toward developing a superfast computer based on the weird reality of quantum physics by showing it is feasible to read data stored in the form of the magnetic “spins” of phosphorus atoms.
The University of Maryland School of Medicine has created a Program in Minority Health and Health Disparities Education and Research (PMHHD). The goal of the program is to educate current and future health professionals about issues related to health disparities, to support relevant multidisciplinary research and to foster quality clinical care for minorities and diverse populations.
Current Issues in Asthma and Chronic Obstructive Pulmonary Disease (COPD) – this event will be hosted in Manchester at the Victoria and Albert Hotel on Tuesday 21 November 2006. This conference will aim to assess the latest trends in asthma and COPD. and the keynote speech will be given by Professor Peter J Helms, ‘Chair of CHM Resp & Allergy Expert Advisory Group”.
A combined analysis of two landmark clinical glaucoma trials — the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS) — confirms the benefit of a five-year risk assessment model to help ophthalmologists better predict which patients have an increased risk of developing glaucoma. Glaucoma is the second leading cause of blindness in the world, affecting approximately 70 million people, and can lead to blindness if left untreated. These new data were presented this week at the annual American Academy of Ophthalmology meeting.
Results of a new survey conducted among more than 1,000 Americans age 45 and older reveal that most adults are not concerned about Chronic Obstructive Pulmonary Disease (COPD), a lung disease that is the fourth leading cause of death in the U.S. According to the survey, only 1 in 10 adults could correctly identify what COPD is, and only 4 percent consider COPD to be a health condition they worry ?the most? about getting, compared against other common chronic diseases, such as Alzheimer?s disease, heart disease, diabetes, or lung cancer. However, more people die from COPD than breast cancer or prostate cancer each year.
Novartis has received a positive opinion supporting European Union regulatory approval for Lucentis? (ranibizumab) as a new treatment option for patients with the “wet” form of age-related macular degeneration, the leading cause of severe vision loss in people over age 50 in the western world.
Chop off a salamander’s leg and a brand new one will sprout in no time. But most animals have lost the ability to replace missing limbs. Now, a research team at the Salk Institute for Biological Studies has been able to regenerate a wing in a chick embryo — a species not known to be able to regrow limbs — suggesting that the potential for such regeneration exists innately in all vertebrates, including humans.
James L. Hargrove, associate professor of foods and nutrition in the University of Georgia, said many nutritionists aren’t even sure of the true origin of the Calorie — or why it’s supposed to be capitalized.His findings are detailed in a study to be published in the December issue of the Journal of Nutrition.
Adolescent girls who live within half a mile of a public park are significantly more physically active than other girls, University of North Carolina at Chapel Hill researchers have found.
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) reported today that a study published in the advanced online edition of the journal Nature supported and elaborated TB4’s significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.